BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 31179712)

  • 21. Herpes zoster after lung transplantation boosts varicella zoster virus-specific adaptive immune responses.
    van Besouw NM; van Hal PT; Zuijderwijk JM; de Kuiper R; Hoek RA; van Weezel JJ; van der Eijk AA; Verjans GM; Weimar W
    J Heart Lung Transplant; 2016 Dec; 35(12):1435-1442. PubMed ID: 27293105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantification of a cell-mediated immune response against varicella zoster virus by assessing responder CD4
    Haredy AM; Takei M; Iwamoto SI; Ohno M; Kosaka M; Hirota K; Koketsu R; Okuno T; Ikuta K; Yamanishi K; Ebina H
    Vaccine; 2019 Aug; 37(36):5225-5232. PubMed ID: 31358406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genital Herpes Zoster as Possible Indicator of HIV Infection.
    Ljubojević Hadžavdić S; Kovačević M; Skerlev M; Zekan Š
    Acta Dermatovenerol Croat; 2018 Dec; 26(4):337-338. PubMed ID: 30665486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased incidence of herpes zoster in patients on renal replacement therapy cannot be explained by intrinsic defects of cellular or humoral immunity to varicella-zoster virus.
    Rondaan C; de Joode AAE; van Assen S; Bos NA; Westerhuis R; Westra J
    Antiviral Res; 2018 Oct; 158():206-212. PubMed ID: 30102958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complications of varicella zoster virus reactivation in HIV-infected homosexual men.
    Veenstra J; van Praag RM; Krol A; Wertheim van Dillen PM; Weigel HM; Schellekens PT; Lange JM; Coutinho RA; van der Meer JT
    AIDS; 1996 Apr; 10(4):393-9. PubMed ID: 8728043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discordant outcomes following failure of antiretroviral therapy are associated with substantial differences in human immunodeficiency virus-specific cellular immunity.
    Price DA; Scullard G; Oxenius A; Braganza R; Beddows SA; Kazmi S; Clarke JR; Johnson GE; Weber JN; Phillips RE
    J Virol; 2003 May; 77(10):6041-9. PubMed ID: 12719595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Characterization of Varicella Zoster Virus-Specific T Cells in Skin and Blood during Aging.
    Vukmanovic-Stejic M; Sandhu D; Seidel JA; Patel N; Sobande TO; Agius E; Jackson SE; Fuentes-Duculan J; Suárez-Fariñas M; Mabbott NA; Lacy KE; Ogg G; Nestle FO; Krueger JG; Rustin MHA; Akbar AN
    J Invest Dermatol; 2015 Jul; 135(7):1752-1762. PubMed ID: 25734814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Zostavax Vaccination on T-Cell Accumulation and Cutaneous Gene Expression in the Skin of Older Humans After Varicella Zoster Virus Antigen-Specific Challenge.
    Patel NP; Vukmanovic-Stejic M; Suarez-Farinas M; Chambers ES; Sandhu D; Fuentes-Duculan J; Mabbott NA; Rustin MHA; Krueger J; Akbar AN
    J Infect Dis; 2018 Sep; 218(suppl_2):S88-S98. PubMed ID: 30247603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Varicella-zoster virus-specific immunity after herpes zoster.
    Hayward A; Levin M; Wolf W; Angelova G; Gilden D
    J Infect Dis; 1991 Apr; 163(4):873-5. PubMed ID: 1849165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and Immunogenicity of Zoster Vaccine Live in Human Immunodeficiency Virus-Infected Adults With CD4+ Cell Counts >200 Cells/mL Virologically Suppressed on Antiretroviral Therapy.
    Benson CA; Andersen JW; Macatangay BJC; Mailliard RB; Rinaldo CR; Read S; Bozzolo DR; Purdue L; Jennings C; Keefer MC; Glesby M; Tebas P; Russell AF; Martin J; Annunziato P; Popmihajlov Z; Lennox JL
    Clin Infect Dis; 2018 Nov; 67(11):1712-1719. PubMed ID: 29590326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subclinical varicella-zoster virus viremia, herpes zoster, and T lymphocyte immunity to varicella-zoster viral antigens after bone marrow transplantation.
    Wilson A; Sharp M; Koropchak CM; Ting SF; Arvin AM
    J Infect Dis; 1992 Jan; 165(1):119-26. PubMed ID: 1309369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of ultra-deep sequencing for detection of varicella-zoster virus antiviral resistance mutations.
    Mercier-Darty M; Boutolleau D; Lepeule R; Rodriguez C; Burrel S
    Antiviral Res; 2018 Mar; 151():20-23. PubMed ID: 29337163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. VZV-specific cell-mediated immunity, but not humoral immunity, correlates inversely with the incidence of herpes zoster and the severity of skin symptoms and zoster-associated pain: The SHEZ study.
    Asada H
    Vaccine; 2019 Oct; 37(44):6776-6781. PubMed ID: 31543415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005-2009.
    Weinmann S; Chun C; Schmid DS; Roberts M; Vandermeer M; Riedlinger K; Bialek SR; Marin M
    J Infect Dis; 2013 Dec; 208(11):1859-68. PubMed ID: 23922376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamic Immune Landscape and VZV-Specific T Cell Responses in Patients With Herpes Zoster and Postherpetic Neuralgia.
    Peng Q; Guo X; Luo Y; Wang G; Zhong L; Zhu J; Li Y; Zeng X; Feng Z
    Front Immunol; 2022; 13():887892. PubMed ID: 35720399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamics of regulatory T-cells during pregnancy: effect of HIV infection and correlations with other immune parameters.
    Richardson K; Weinberg A
    PLoS One; 2011; 6(11):e28172. PubMed ID: 22140535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term and long-term clinical and immunological consequences of stopping antiretroviral therapy in HIV-infected patients with preserved immune function.
    Imaz A; Olmo M; Peñaranda M; Gutiérrez F; Romeu J; Larrousse M; Domingo P; Oteo JA; Curto J; Vilallonga C; Masiá M; López-Aldeguer J; Iribarren JA; Podzamczer D;
    Antivir Ther; 2013; 18(1):125-30. PubMed ID: 22805174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of functional TCR-epitope interaction is associated with herpes zoster through reduced downstream T cell activation.
    Boeren M; de Vrij N; Ha MK; Valkiers S; Souquette A; Gielis S; Kuznetsova M; Schippers J; Bartholomeus E; Van den Bergh J; Michels N; Aerts O; Leysen J; Bervoets A; Lambert J; Leuridan E; Wens J; Peeters K; Emonds MP; Elias G; Vandamme N; Jansens H; Adriaensen W; Suls A; Vanhee S; Hens N; Smits E; Van Damme P; Thomas PG; Beutels P; Ponsaerts P; Van Tendeloo V; Delputte P; Laukens K; Meysman P; Ogunjimi B
    Cell Rep; 2024 Apr; 43(4):114062. PubMed ID: 38588339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An inverse correlation of VZV skin-test reaction, but not antibody, with severity of herpes zoster skin symptoms and zoster-associated pain.
    Asada H; Nagayama K; Okazaki A; Mori Y; Okuno Y; Takao Y; Miyazaki Y; Onishi F; Okeda M; Yano S; Kumihashi H; Gomi Y; Maeda K; Ishikawa T; Iso H; Yamanishi K;
    J Dermatol Sci; 2013 Mar; 69(3):243-9. PubMed ID: 23183011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD8
    Fenoglio D; Dentone C; Signori A; Di Biagio A; Parodi A; Kalli F; Nasi G; Curto M; Cenderello G; De Leo P; Bartolacci V; Orofino G; Nicolini LA; Taramasso L; Fiorillo E; Orrù V; Traverso P; Bruzzone B; Ivaldi F; Mantia E; Guerra M; Negrini S; Giacomini M; Bhagani S; Filaci G
    J Allergy Clin Immunol; 2018 Jun; 141(6):2220-2233.e4. PubMed ID: 29103633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.